Literature DB >> 16479403

Café-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind?

Sofie De Schepper1, Joachim Boucneau, Yves Vander Haeghen, Ludwine Messiaen, Jean-Marie Naeyaert, Jo Lambert.   

Abstract

Solitary café-au-lait spots are quite common in the general population but multiple café-au-lait macules (CALM) are often indicative of an underlying genetic disorder. The frequency of having more than five CALM is rare in normal individuals and is therefore considered as a cut-off for the diagnosis of neurofibromatosis type 1 (NF1). The etiopathogenesis of these macules is still very obscure. In this study we compared epidermal melanocyte and dermal mast cell numbers between four groups: control normal and control CALM skin, and NF1 normal and NF1 CALM skin and elaborated a possible role for stem cell factor (SCF) in CALM formation. The groups were analyzed by immunohistochemistry for numerical analysis of the melanocyte and mast cell population and by ELISA, western blot analysis and real-time quantitative PCR for further determination of the role of SCF. We found a significant increase in melanocyte density in NF1 CALM skin compared with the isolated CALM in control individuals. However, both groups displayed a similar increase in mast cell density. In addition, we found increased levels of soluble SCF in NF1 CALM and in NF1 normal fibroblast supernatant. We conclude that SCF is an important cytokine in NF1 skin, but that additional (growth) factors and/or genetic mechanisms are needed to induce NF1-specific CALM hyperpigmentation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16479403     DOI: 10.1007/s00403-006-0644-6

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  13 in total

1.  Phenotypic variability among café-au-lait macules in neurofibromatosis type 1.

Authors:  Kevin P Boyd; Liyan Gao; Rui Feng; Mark Beasley; Ludwine Messiaen; Bruce R Korf; Amy Theos
Journal:  J Am Acad Dermatol       Date:  2010-06-03       Impact factor: 11.527

2.  Neurofibromatosis: chronological history and current issues.

Authors:  João Roberto Antônio; Eny Maria Goloni-Bertollo; Lívia Arroyo Trídico
Journal:  An Bras Dermatol       Date:  2013 May-Jun       Impact factor: 1.896

Review 3.  The etiology and molecular genetics of human pigmentation disorders.

Authors:  Laura L Baxter; William J Pavan
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2012-05-17       Impact factor: 5.814

Review 4.  The pathoetiology of neurofibromatosis 1.

Authors:  Eeva-Mari Jouhilahti; Sirkku Peltonen; Anthony M Heape; Juha Peltonen
Journal:  Am J Pathol       Date:  2011-03-31       Impact factor: 4.307

5.  Multiscale confocal photoacoustic dermoscopy to evaluate skin health.

Authors:  Haigang Ma; Zhiyang Wang; Zhongwen Cheng; Guo He; Ting Feng; Chao Zuo; Haixia Qiu
Journal:  Quant Imaging Med Surg       Date:  2022-05

Review 6.  Neurofibromatosis type 1.

Authors:  Kevin P Boyd; Bruce R Korf; Amy Theos
Journal:  J Am Acad Dermatol       Date:  2009-07       Impact factor: 11.527

7.  Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1.

Authors:  Ophélia Maertens; Sofie De Schepper; Jo Vandesompele; Hilde Brems; Ine Heyns; Sandra Janssens; Frank Speleman; Eric Legius; Ludwine Messiaen
Journal:  Am J Hum Genet       Date:  2007-06-20       Impact factor: 11.025

8.  Cutaneous findings in Fanconi anemia.

Authors:  Jenna L Ruggiero; Melissa Dodds; Rebecca Freese; Ingrid C Polcari; Sheilagh Maguiness; Kristen P Hook; Christina Boull
Journal:  J Am Acad Dermatol       Date:  2020-08-18       Impact factor: 11.527

9.  Differential expression of wound fibrotic factors between facial and trunk dermal fibroblasts.

Authors:  Masakazu Kurita; Mutsumi Okazaki; Akiko Kaminishi-Tanikawa; Mamoru Niikura; Akihiko Takushima; Kiyonori Harii
Journal:  Connect Tissue Res       Date:  2012-07-24       Impact factor: 3.417

10.  Somatic deletion of the NF1 gene in a neurofibromatosis type 1-associated malignant melanoma demonstrated by digital PCR.

Authors:  Albert Rübben; Birke Bausch; Arjen Nikkels
Journal:  Mol Cancer       Date:  2006-09-10       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.